Latest Ikarian Capital, LLC Stock Portfolio
$574Million– No. of Holdings #85
Ikarian Capital, LLC Performance:
2024 Q2: -12.88%YTD: 6.23%2023: 19.29%
Performance for 2024 Q2 is -12.88%, and YTD is 6.23%, and 2023 is 19.29%.
About Ikarian Capital, LLC and 13F Hedge Fund Stock Holdings
Ikarian Capital, LLC is a hedge fund based in DALLAS, TX. On 18-Sep-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $375.1 Millions. In it's latest 13F Holdings report, Ikarian Capital, LLC reported an equity portfolio of $574.1 Millions as of 30 Jun, 2024.
The top stock holdings of Ikarian Capital, LLC are SRPT, CRNX, TARS. The fund has invested 5.6% of it's portfolio in SAREPTA THERAPEUTICS INC and 4.6% of portfolio in CRINETICS PHARMACEUTICALS IN.
The fund managers got completely rid off UNIQURE NV (QURE), APELLIS PHARMACEUTICALS INC (APLS) and ASTRIA THERAPEUTICS INC (ATXS) stocks. They significantly reduced their stock positions in ANNEXON INC (ANNX), IMMUNIC INC (IMUX) and VOYAGER THERAPEUTICS INC (VYGR). Ikarian Capital, LLC opened new stock positions in ENLIVEN THERAPEUTICS INC, AMGEN INC (AMGN) and VIKING THERAPEUTICS INC (VKTX). The fund showed a lot of confidence in some stocks as they added substantially to TERNS PHARMACEUTICALS INC (TERN), Q32 BIO INC and ELEVATION ONCOLOGY INC (ELEV).
The top stock holdings of Ikarian Capital, LLC are SRPT, CRNX, TARS. The fund has invested 5.6% of it's portfolio in SAREPTA THERAPEUTICS INC and 4.6% of portfolio in CRINETICS PHARMACEUTICALS IN.
The fund managers got completely rid off UNIQURE NV (QURE), APELLIS PHARMACEUTICALS INC (APLS) and ASTRIA THERAPEUTICS INC (ATXS) stocks. They significantly reduced their stock positions in ANNEXON INC (ANNX), IMMUNIC INC (IMUX) and VOYAGER THERAPEUTICS INC (VYGR). Ikarian Capital, LLC opened new stock positions in ENLIVEN THERAPEUTICS INC, AMGEN INC (AMGN) and VIKING THERAPEUTICS INC (VKTX). The fund showed a lot of confidence in some stocks as they added substantially to TERNS PHARMACEUTICALS INC (TERN), Q32 BIO INC and ELEVATION ONCOLOGY INC (ELEV).
Ikarian Capital, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Ikarian Capital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Ikarian Capital, LLC made a return of -12.88% in the last quarter. In trailing 12 months, it's portfolio return was 37.28%.
New Buys
| Ticker | $ Bought |
|---|---|
| enliven therapeutics inc | 13,707,700 |
| amgen inc | 11,966,800 |
| viking therapeutics inc | 7,329,270 |
| cartesian therapeutics inc | 6,546,410 |
| neurocrine biosciences inc | 5,506,800 |
| rezolute inc | 3,886,100 |
| silence therapeutics plc | 3,293,320 |
| inhibrx biosciences inc | 3,259,100 |
New stocks bought by Ikarian Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| terns pharmaceuticals inc | 418 |
| q32 bio inc | 388 |
| elevation oncology inc | 366 |
| lenz therapeutics inc | 140 |
| nuvalent inc | 49.21 |
| nurix therapeutics inc | 46.83 |
| sarepta therapeutics inc | 33.71 |
| marinus pharmaceuticals inc | 31.27 |
Additions to existing portfolio by Ikarian Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| annexon inc | -72.95 |
| immunic inc | -69.39 |
| voyager therapeutics inc | -69.12 |
| verona pharma plc | -46.41 |
| mind medicine mindmed inc | -45.38 |
| corbus pharmaceuticals hldgs | -44.65 |
| nuvation bio inc | -43.42 |
| macrogenics inc | -37.12 |
Ikarian Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| uniqure nv | -2,439,490 |
| astria therapeutics inc | -1,980,170 |
| avrobio inc | -965,198 |
| hookipa pharma inc | -377,913 |
| aslan pharmaceuticals ltd | -6,273 |
| apellis pharmaceuticals inc | -2,062,710 |
| finch therapeutics group inc | -18,126 |
| eyepoint pharmaceuticals inc | -21,642 |
Ikarian Capital, LLC got rid off the above stocks
Sector Distribution
Ikarian Capital, LLC has about 84.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 84.9 |
| Others | 15.1 |
Market Cap. Distribution
Ikarian Capital, LLC has about 16.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 31.3 |
| MID-CAP | 24.4 |
| LARGE-CAP | 16.5 |
| UNALLOCATED | 15.1 |
| MICRO-CAP | 9.2 |
| NANO-CAP | 3.4 |
Stocks belong to which Index?
About 49.2% of the stocks held by Ikarian Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 50.8 |
| RUSSELL 2000 | 45.5 |
| S&P 500 | 3.7 |
Ikarian Capital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Ikarian Capital, LLC
Ikarian Capital, LLC has 85 stocks in it's portfolio. About 29.3% of the portfolio is in top 10 stocks. AVTE proved to be the most loss making stock for the portfolio. SRPT was the most profitable stock for Ikarian Capital, LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABEO | abeona therapeutics inc | 0.57 | 768,593 | 3,258,840 | reduced | -13.5 | ||
| ABOS | acumen pharmaceuticals inc | 0.11 | 266,435 | 644,774 | unchanged | 0.00 | ||
| ACHL | achilles therapeutics plc | 0.20 | 1,443,180 | 1,176,190 | unchanged | 0.00 | ||
| ALLK | allakos inc | 0.17 | 972,675 | 972,675 | added | 4.29 | ||
| AMGN | amgen inc | 2.08 | 38,300 | 11,966,800 | new | |||
| AMLX | amylyx pharmaceuticals inc | 0.09 | 274,551 | 521,647 | reduced | -17.17 | ||
| ANEB | anebulo pharmaceuticals inc | 0.07 | 157,862 | 430,964 | unchanged | 0.00 | ||
| ANNX | annexon inc | 0.32 | 380,000 | 1,862,000 | reduced | -72.95 | ||
| APLS | apellis pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARQT | arcutis biotherapeutics inc | 0.79 | 489,642 | 4,553,670 | reduced | -16.96 | ||
| ASLN | aslan pharmaceuticals ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATXS | astria therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVRO | avrobio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVTE | aerovate therapeutics inc | 0.11 | 367,965 | 610,822 | unchanged | 0.00 | ||
| AVTX | avalo therapeutics inc | 0.12 | 54,730 | 682,483 | added | 17.33 | ||
| BBIO | bridgebio pharma inc | 1.47 | 332,013 | 8,409,890 | added | 17.73 | ||
| BCLI | brainstorm cell therapeutics | 0.00 | 90,242 | 30,547 | unchanged | 0.00 | ||
| CMPS | compass pathways plc | 0.32 | 302,908 | 1,829,560 | new | |||
| CPRX | catalyst pharmaceuticals inc | 1.40 | 518,386 | 8,029,800 | unchanged | 0.00 | ||
| CRBP | corbus pharmaceuticals hldgs | 2.44 | 309,540 | 14,006,700 | reduced | -44.65 | ||